Is KCDMF or JNJ a better dividend investment in 2026?

KCDMF currently yields 5.86% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: KCDMF offers higher current income.

What is the dividend yield difference between KCDMF and JNJ?

KCDMF has a forward dividend yield of 5.86% ($0.13/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 2.50 percentage points.

Home › Compare › KCDMF vs JNJ

KCDMF vs JNJ: Dividend Comparison 2026

KCDMF yields 5.86% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 KCDMF wins by $86.0K in total portfolio value

INVESTMENT

TIME HORIZON10 years

KCDMF

● Live price

5.86%

Share price

$2.22

Annual div

$0.13

5Y div CAGR

28.9%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$106.1K

Annual income

$29,037.46

Full KCDMF calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — KCDMF vs JNJ

📍 KCDMF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	KCDMF	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, KCDMF + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

KCDMF pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KCDMF

Annual income on $10K today (after 15% tax)

$497.75/yr

After 10yr DRIP, annual income (after tax)

$24,681.84/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, KCDMF beats the other by $23,978.23/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KCDMF + JNJ for your $10,000?

KCDMF: 50%JNJ: 50%

100% JNJ50/50100% KCDMF

Portfolio after 10yr

$63.0K

Annual income

$14,932.62/yr

Blended yield

23.69%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

KCDMF

No analyst data

Altman Z

4.4

Piotroski

9/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KCDMF buys

JNJ buys

No recent congressional trades found for KCDMF or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricKCDMFJNJ

Forward yield	5.86% ✓	3.36%
Annual dividend / share	$0.13	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	28.9% ✓	5.8%
Portfolio after 10y	$106.1K ✓	$20.0K
Annual income after 10y	$29,037.46 ✓	$827.78
Total dividends collected	$76.3K ✓	$5.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: KCDMF vs JNJ ($10,000, DRIP)

Year	KCDMF Portfolio	KCDMF Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$11,455	$754.82	$10,676	$355.77	+$779.00 → KCDMF
2	$13,298	$1,041.60	$11,407	$389.39	+$1.9K → KCDMF
3	$15,686	$1,456.72	$12,198	$426.53	+$3.5K → KCDMF
4	$18,854	$2,069.95	$13,056	$467.62	+$5.8K → KCDMF
5	$23,171	$2,997.22	$13,987	$513.12	+$9.2K → KCDMF
6	$29,230	$4,437.41	$14,998	$563.56	+$14.2K → KCDMF
7	$38,020	$6,743.56	$16,098	$619.52	+$21.9K → KCDMF
8	$51,248	$10,566.66	$17,295	$681.69	+$34.0K → KCDMF
9	$71,993	$17,158.23	$18,599	$750.82	+$53.4K → KCDMF
10	$106,070	$29,037.46	$20,022	$827.78	+$86.0K → KCDMF

KCDMF vs JNJ: Complete Analysis 2026

KCDMF — Stock

Kimberly-Clark de México, S. A. B. de C. V., together with its subsidiaries, manufactures and commercializes disposable products for daily use by consumers in Mexico. The company offers diapers, pull-up training pants, swim diapers, wet wipes, shampoos, cream and bar soaps, and feeding products for babies; beauty products, including bar soaps, liquid hand soaps, foaming liquid soaps, liquid body washes, micellar water, and makeup removing wipes; and underwear, protectors, feminine pads, and prefolded products for adults. It also provides toilet paper, napkins, facial tissues, and paper towels for home; feminine pads, panty liners, tampons, and intimate wipes for women; and dispensers, jumbo roll toilet papers, paper towels, hand towels, anti-bacterial gel, disinfecting spray, facemasks, and industrial cleaning cloths for professional use. The company offers its products primarily under the Huggies, KleenBebe, Pull-Ups, Evenflo, Kleenex, Kotex, Depend, Cottonelle, Pétalo, Suavel, Vogue, Sanitas, Marli y Kimlark, Jabón Escudo Antibacterial, and Jabones Kleenex brands. The company also exports its products. Kimberly-Clark de México, S. A. B. de C. V. was founded in 1925 and is based in Mexico City, Mexico.

Full KCDMF Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this KCDMF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KCDMF vs SCHD KCDMF vs JEPI KCDMF vs O KCDMF vs KO KCDMF vs MAIN KCDMF vs ABBV KCDMF vs MRK KCDMF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.